Welcome to LookChem.com Sign In|Join Free

CAS

  • or

58521-45-2

Post Buying Request

58521-45-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

58521-45-2 Usage

General Description

Tert-butyl (S)1-formyl-3-methylbutylcarbamate is a chemical compound used as a carbamate derivative in the manufacture of pharmaceuticals and agrochemicals. It is a tertiary carbamate with a tert-butyl group attached to the nitrogen atom and a formyl group attached to the carbon atom. Tert-butyl (S)1-formyl-3-methylbutylcarbamate is often utilized as a protecting group in peptide synthesis due to its stability and ease of removal. Additionally, it may have applications in the field of organic chemistry as a reagent or intermediate in various synthetic routes. Further research is needed to fully explore the potential uses and properties of this chemical compound.

Check Digit Verification of cas no

The CAS Registry Mumber 58521-45-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,5,2 and 1 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 58521-45:
(7*5)+(6*8)+(5*5)+(4*2)+(3*1)+(2*4)+(1*5)=132
132 % 10 = 2
So 58521-45-2 is a valid CAS Registry Number.

58521-45-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamate

1.2 Other means of identification

Product number -
Other names BOC-LEU-CHO

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58521-45-2 SDS

58521-45-2Relevant articles and documents

Isolation and Total Synthesis of Hoshinolactam, an Antitrypanosomal Lactam from a Marine Cyanobacterium

Ogawa, Hidetoshi,Iwasaki, Arihiro,Sumimoto, Shimpei,Iwatsuki, Masato,Ishiyama, Aki,Hokari, Rei,Otoguro, Kazuhiko,Omura, Satoshi,Suenaga, Kiyotake

, p. 890 - 893 (2017)

In the search for new antiprotozoal substances, hoshinolactam, an antitrypanosomal lactam, was isolated from a marine cyanobacterium. The gross structure was elucidated by spectroscopic analyses, and the absolute configuration was determined by the first total synthesis. Hoshinolactam showed potent antitrypanosomal activity with an IC50 value of 3.9 nM without cytotoxicity against human fetal lung fibroblast MRC-5 cells (IC50 > 25 μM).

Synthesis of the C-13 side chain precursors of the 9-dihydrotaxane analogue ABT-271.

Leanna,DeMattei,Li,Nichols,Rasmussen,Morton

, p. 3627 - 3630 (2000)

N-Boc-L-Leucinol was converted to two C-13 side chain precursors of the 9-dihydrotaxane analogue ABT-271. The trans-oxazolidine acid 4 and the cis-Boc-lactam 2b were prepared in 44% and 40% overall yield, respectively, and with excellent (>98%) stereochemical purity.

Synthesis of E- and Z-alkene dipeptide isosteres

Bohnstedt, Adolph C.,Prasad, J. V. N. Vara,Rich, Daniel H.

, p. 5217 - 5220 (1993)

The synthesis of MeLeu and MeLeu-D-Leu alkene dipeptide isosteres are described. Isosteres with an E-alkene bond were synthesized stereoselectively by employing the [2, 3] Wittig rearrangement to control double bond geometry and C-2 configuration. Z-alkene isosters were obtained as an easily separable mixture of diastereomers via alkylation of a Z-alkene MeLeu-Gly isostere that was obtained using a Z-selective Wittig reaction as the key step. All isosteres are isolated with high stereochemical purity.

Structure Determination, Biosynthetic Origin, and Total Synthesis of Akazaoxime, an Enteromycin-Class Metabolite from a Marine-Derived Actinomycete of the Genus Micromonospora

Igarashi, Yasuhiro,Matsuyuki, Yoe,Yamada, Masayuki,Fujihara, Nodoka,Harunari, Enjuro,Oku, Naoya,Karim, Md. Rokon Ul,Yang, Taehui,Yamada, Katsuhisa,Imada, Chiaki,Fukaya, Keisuke,Urabe, Daisuke

, p. 6528 - 6537 (2021)

A new enteromycin-class antibiotic, akazaoxime (1), possessing an aldoxime functionality in place of O-methyl nitronic acid, was isolated from the cultured extract of a marine-derived actinomycete of the genus Micromonospora, along with known A-76356 (2). The structure of 1, including the absolute stereochemistry of three chiral centers, was established by comprehensive analysis of nuclear magnetic resonance (NMR) and mass spectrometry data coupled with magnetic anisotropy analysis of its phenylglycine methyl ester derivatives. The stereochemistry of 2, not determined previously, was proven to be the same as that of 1 on the basis of the similarity of their NMR and specific rotation data. Precursor feeding experiments using 13C-labeled compounds elucidated that the carbon skeletons of 1 and 2 are constructed from propionate (methylmalonate), leucine, and glycine. Establishment of the concise and flexible synthetic route to 1 enabled us to implement biological evaluation of 1 and its unnatural analogues, demonstrating weak to moderate antimicrobial activities of 1 against Gram-positive Kocuria rhizophila [minimum inhibitory concentration (MIC) of 50 μg/mL] and those of synthetic analogues against a plant pathogen Glomerella cingulata (MIC of 50 μg/mL) and a human pathogen Trichophyton rubrum (MIC of 25-50 μg/mL).

Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities

Ajayi, Oluwatomi,Collins, Jasmine,Crown, Olamide,Nyamwihura, Rogers,Ogungbe, Ifedayo Victor,Zhang, Huaisheng

, (2020/05/18)

The number of reported cases of Human African Trypanosmiasis (HAT), caused by kinetoplastid protozoan parasite Trypanosoma brucei, is declining in sub-Saharan Africa. Historically, such declines are generally followed by periods of higher incidence, and one of the lingering public health challenges of HAT is that its drug development pipeline is historically sparse. As a continuation of our work on new antitrypanosomal agents, we found that partially saturated quinoline-based vinyl sulfone compounds selectively inhibit the growth of T. brucei but displayed relatively weak inhibitory activity towards T. brucei's cysteine protease rhodesain. While two nitroaromatic analogues of the quinoline-based vinyl sulfone compounds displayed potent inhibition of T. brucei and rhodesain. The quinoline derivatives and the nitroaromatic-based compounds discovered in this work can serve as leads for ADME-based optimization and pre-clinical investigations.

COMPOSITION FOR TREATMENT AND/OR PREVENTION OF PERIPHERAL NERVE DISORDER

-

Paragraph 0185; 0216, (2019/10/29)

The present invention provides a means for treating and/or preventing peripheral nerve disorder by facilitating regeneration of peripheral nerves. Specifically, the present invention provides a composition for treating and/or preventing peripheral nerve d

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 58521-45-2